Skip to main content
FDA Shortage Check

Is Rifadin (Rifampin Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Rifadin: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Discontinuation of the manufacture of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: Q4 2026”. Manufacturer’s estimate, Mylan Institutional, a Viatris Company, Oct 19, 2026
DRUG
Rifadin
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Feb 17, 2021
LAST FDA UPDATE
Oct 19, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 3 presentations: 2 unavailable · 1 limited · 0 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Rifampin Injection. 4 presentations from 3 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Fresenius Kabi USA, LLC1 presentation · 1 limited

Contact (FDA's listing): 888-386-1300

  • 600 mg

    Rifampin, Injection, 600 mg (NDC 63323-351-20)

    Check wholesalers for inventory

    NDC 63323-351-20Reverified

    Limited Availability

Mylan Institutional, a Viatris Company1 presentation · 1 unavailable

Contact (FDA's listing): 800-796-9526

  • 600 mg

    Rifampin, Injection, 600 mg (NDC 67457-445-60)

    Estimated recovery: Q4 2026

    NDC 67457-445-60Reverified

    Unavailable

Sanofi-Aventis U.S. LLC1 presentation · 1 unavailable

Contact (FDA's listing): 800-633-1610

  • 600 mg

    Rifadin, Injection, 600 mg (NDC 0068-0597-01)

    Discontinuation of the manufacture of the drug

    NDC 0068-0597-01Reverified

    Unavailable

What the manufacturers told FDA

  • Mylan Institutional, a Viatris Company · ‘Estimated recovery: Q4 2026’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Discontinuation of the manufacture of the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Other products with the same ingredient and form

A discontinuation “does not necessarily create a shortage” (FDA).

  • Sanofi-Aventis U.S. LLC told FDA it will discontinue Rifadin (posted ).

    “Discontinuation of the manufacture of the drug”

    FDA listing: Rifampin Injection

Shown as FDA status, not as suggestions.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Rifadin in shortage?
Yes. As of Oct 24, 2026, FDA lists Rifampin Injection as currently in shortage: 3 presentations, 2 unavailable and 1 limited.
When will the Rifadin shortage end?
FDA gives no end date. 1 presentation carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Rifadin?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.